Dystroglycanopathy is characterized by reduced or lack of matriglycan, a cellular receptor for laminin as well as other extracellular matrix proteins. This evidence concerns the gene LAMB2 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.